Whan In Pharm Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Whan In Pharm Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Whan In Pharm, the average price target is ₩21000.00, with a high estimate of ₩21000.00 and a low estimate of ₩21000.00. That is a potential upside of approximately 47.68% from the last closing price of ₩14220.00 on May, 2024.
47.68% Upside
Whan In Pharm Fair Value Forecast for 2023 - 2025 - 2030
Whan In Pharm's Price has decreased by 100.00% In the last four years, from ₩9008.16 to ₩0.00. In the next year, analysts predict that Fair Value will jump to ₩0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that Fair Value will grow by 100.00%.
Whan In Pharm Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Whan In Pharm's Revenue has grown, moving from ₩171.71B to ₩230.39B – an increase of 34.18%. In the following year, the 0 analysts surveyed believe that Whan In Pharm's Revenue will decrease by 9.23%, reaching ₩209.12B. According to professionals, by 2030, Whan In Pharm's Revenue will have decreased by 11.30%, falling down to ₩204.36B.
.jpg)
Whan In Pharm Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Whan In Pharm's Dividend per Share has decreased from ₩300.00 to ₩300.00 – a 0.00% drop! The next year, 0 experts forecast that Whan In Pharm's Dividend per Share will decrease by 0.00%, reaching ₩300.00. In 2030, professionals predict that Whan In Pharm's Dividend per Share will decrease by 0.00%, reaching ₩300.00.
Whan In Pharm EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for Whan In Pharm has grown by 13.36%, going from ₩32.49B to ₩36.83B. For the next year, 0 analysts project Whan In Pharm's EBITDA to drop by 3.99%, reaching ₩35.36B. By 2030, professionals believe that Whan In Pharm's EBITDA will decrease by 3.77%, reaching ₩35.44B – a concerning trend for the company.
Whan In Pharm EBIT Forecast for 2023 - 2025 - 2030
Whan In Pharm's EBIT has grown in the last three years, jumping from ₩28.42B to ₩30.17B – an increase of 6.16%. According to 0 prominent analysts, Whan In Pharm's EBIT will fall by 1.80% in the next year, reaching ₩29.63B. By 2030, professionals believe that Whan In Pharm's EBIT will decrease by 0.46%, reaching ₩30.03B – a concerning trend for the company.
Whan In Pharm EPS Price Prediction Forecast for 2023 - 2025 - 2030
Whan In Pharm's EPS has decreased by 100.00% In the last four years, from ₩1532.00 to ₩0.00. In the next year, analysts predict that EPS will jump to ₩0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that EPS will grow by 100.00%.
.jpg)